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Abstract
Objectives It has recently been shown that enamel matrix de-
rivative (EMD) components (Fraction C, containing <6 kDa
peptides (mainly a 5.3 kDa tyrosine-rich amelogenin peptide
(TRAP)), and Fraction A, containing a mixture of >6 kDa
peptides (including a leucine-rich amelogenin peptide
(LRAP))) differentially regulate osteogenic differentiation of
periodontal ligament (PDL) cells. The present study examined
whether EMD and the EMD Fractions (i) bind and internalize
into PDL cells and (ii) precipitate and form insoluble com-
plexes on PDL cells.
Materials and methods Biotin-labelled EMD/EMD Fractions
were incubated with PDL cells under various different culture
conditions and confocal and electron microscopies were car-
ried out to examine the binding and intracellular trafficking of
these proteins.
Results The results reported here show, for the first time, that
at least some components in Fraction A and the TRAP peptide
in Fraction C can bind and be internalized by human PDL
cells via receptor-mediated endocytosis. In addition, Fraction
A was found to form insoluble aggregate-like structures on
PDL cells, whereas Fraction C was soluble in culture media.
Conclusion Soluble amelogenin isoform TRAP appears to be
internalizing into a subset of PDL cells. Moreover, TRAP
uptake is most likely controlled by receptor-mediated
endocytosis.
Clinical relevance Information on interaction between PDL
cells and EMD/TRAPmight prove useful in designing targeted
interventions (i.e. use of chemically prepared soluble
amelogenin peptides) to repair/regenerate periodontal tissues.
Such interventions can also (i) avoid the use of rather crude
animal-derived enamel matrix protein (EMP)/EMD preparation
and (ii) preparation of cost-effective and more controlled chem-
ically synthesized amelogenin peptides for the clinical use.
Keywords EMD . Periodontal ligament cells . Intracellular
trafficking . EMD uptake . Receptor-mediated endocytosis
Introduction
Enamel matrix protein (EMP) is a heterogeneous mixture of
mainly amelogenin-derived proteins produced during tooth
development. Previous studies in our laboratory have shown
that a heat-treated form of EMP, enamel matrix derivative
(EMD), has the ability to modulate mesenchymal and non-
mesenchymal differentiation pathways of adult human peri-
odontal ligament (PDL) cells [1–4]. Moreover, certain frac-
tions derived from EMD (Fraction C containing <6 kDa pep-
tides (mainly a 5.3 kDa tyrosine-rich amelogenin peptide
(TRAP)) and Fraction A containing a mixture of >6 kDa
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peptides (including a leucine-rich amelogenin peptide
(LRAP), sheathlin proteins and full-length amelogenin), sep-
arated from EMD by industrial scale protein fractionation
methodologies [5]), have been reported to differentially regu-
late a number of PDL cell differentiation activities, including
osteogenesis, vasculogenesis and angiogenesis in vitro [1, 3,
4]. Although the mechanism(s) involved are not yet clear,
studies of mouse amelogenins and amelogenin isoforms have
shown that they can bind to and become internalized via the
lysosomal-associated membrane protein-1 (LAMP-1) and can
regulate dentine, cementum and PDL formation in murine
embryonic dental follicle cells [6–11]. Further, some compo-
nent(s) present in EMD (comprising amelogenins, sheathlins
and enamelins (Brookes et al. 1995; Hu et al. 1997), as noted
above) may be internalized into osteoblasts via clathrin-coated
pits [12]. These observations suggest a pivotal role of receptor-
mediated endocytosis in the uptake of ‘soluble’ EMP/EMD
components [7, 9, 10], although the initial binding to the oste-
oblast cell membrane and intracellular transport and fate and
the specific component(s) involved are not yet known [12].
In addition, EMD has also been observed to precipitate on
human PDL tissue sections ex vivo, forming spheres or short
rod-like structures [13], and also on the surface of PDL cells
in vitro, stimulating cell proliferation, ECM production and
osteogenic differentiation [13–15]. These data suggest the
possibility that such ‘insoluble’ complexes of the full-length
hydrophobic amelogenin protein, a main component of EMD,
may be at least partially responsible for some of the effects on
PDL cell activity [13–15].
To clarify the interaction between the commercial heat-
treated preparation of EMD and the EMD fractions with
PDL cells, experiments were carried out to determine whether
EMD and the EMD Fractions (C and A) (i) bind to PDL cells
and are internalized and transported intracellularly and (ii)
precipitate and form insoluble complexes on PDL cells.
Materials and methods
Isolation and culture of primary human PDL cells
PDL cells were obtained from PDL tissue of patients under-
going routine third molar tooth extractions, as previously de-
scribed [3]. Informed consent was in accordance with the pro-
tocol approved by the Joint Research and Ethics Committee of
the Eastman Dental Institute and Hospital. The cells were
cultured in growth medium (GM) comprising α-modified Ea-
gle’s medium (α-MEM) (Gibco Life Technologies Ltd, Pais-
ley, UK) and 10 % fetal calf serum (FCS) (PAA Laboratories,
Yeovil, UK) supplemented with 200 U/ml penicillin,
200 μg/ml streptomycin and 2 mM L-glutamine (all from
Gibco) at 37 °C in a humidified atmosphere of 5 % CO2 in
air. Three separate PDL cell populations from three different
donors (male, aged between 18 and 25) were used between
passages 3 and 6.
Treatment of cells with EMD components
Biotin-labelled EMD and the EMD-derived <6 kDa (Fraction
C) and >6 kDa (Fraction A) sub-fractions (provided by Institut
Straumann, Basel, Switzerland) were diluted in 0.1 % acetic
acid, and 10 μg/ml (a concentration which has been shown to
modulate a number of differentiation pathways [1, 3, 4]) was
added directly to the PDL cultures at 50–60 % confluence, as
described below. In addition, a chemically synthesized biotin-
labelled 45-amino acid (tyrosine-rich amelogenin peptide;
TRAP) peptide sequence
½NH2MPLPPHPGHPGYINFSYEVLTPLKWYQNMIR
HPYTSYGYEPMGGW–COOH
provided by Institut Straumann), the major component of
Fraction C, was diluted in cell culture grade water (Thermo
Scientific, Basingstoke, UK) and added to the cultures at
10 μg/ml, based on previous results [3].
Binding and intracellular uptake of EMD and the EMD
Fractions by PDL cells
To assess cell binding, PDL cells were seeded onto 24-well
plates on glass coverslips at a density of 104 cells/well and
cultured in GM for 2 days. At approximately 50–60 % con-
fluence, the medium was replaced with cold GM containing
10 μg/ml of EMD, Fraction C or Fraction A that had been
biotin-labelled. After 45 min at 4 °C, the cells were washed
with cold phosphate-buffered saline (PBS), fixed with 4 %
paraformaldehyde (PFA) for 15 min, reacted with Alexa
Fluor-streptavidin (Cat#S-11226, Invitrogen, Paisley, UK)
for 30 min, washed, overlaid with mounting medium and
glass coverslips and visualized under the fluorescence micro-
scope. To determine whether the biotin-labelled EMD and the
EMD Fractions were membrane-associated, replicate cultures
previously incubated with EMD and the EMD fractions at
4 °C were washed, treated with enzyme-free dissociation so-
lution (Invitrogen) at 4 °C for 10 min, scrapped using a cell
scrapper, fixed with 4 % PFA for 15 min and detached cells
centrifuged at 1500 rpm for 5 min. Cell pellets were washed
and resuspended in PBS, reacted with Alexa Fluor-
streptavidin for 30 min, washed, air-dried on a glass slide
and visualized under the fluorescence microscope as de-
scribed above.
To examine whether EMD and the EMD Fractions were
internalized after the initial 45 min of incubation at 4 °C as
above, the cells were washed, incubated in GM at 37 °C for 3
and 6 h, fixed with 4 % PFA, permeabilized using 0.1 %
Triton-X for 10 min and reacted with Alexa Fluor-
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streptavidin (Invitrogen) for 30 min. To ensure that any posi-
tive staining observed (i.e. red fluorescence) after incubation
at 37 °C was not due to membrane-bound/extracellular ligand,
replicate cultures (incubated for 3 h at 37 °C) were treated with
trypsin-EDTA for 5 min prior to PFA fixation. The detached
cells were centrifuged at 1500 rpm for 5 min, re-cultured for a
further period of 3 h at 37 °C to allow the cells to re-adhere
and spread, fixed with 4 % PFA, permeabilized and reacted
with Alexa Fluor-streptavidin for 30 min as above. Nuclei
were stained blue using Hoechst dye.
Intracellular localization of EMD and the EMD Fractions
After binding, the biotinylated EMD, Fraction C and Fraction
Awere co-localized with markers of the trans-Golgi network
(TGN) and lysosomes using specific antibodies as follows.
The cells were seeded and cultured for 2 days on glass cover-
slips in 24-well plates and then incubated with the biotin-
labelled ligands at 4 °C for 45 min. The cells were then
washed, incubated in GM at 37 °C for 45 min and 3 h, fixed
with 4 % PFA and permeabilized for 10 min. These time
points were used because a number of ligands (mouse
amelogenin isoforms, Wnt and non-toxic β-subunit of Shiga
toxin) have been shown to be transported to the TGN after 30
to 60min and then to the lysosomes after 2 to 6 h of incubation
at 37 °C following binding to the cell surface [7, 16, 17]. Thus,
PDL samples were immunostained for the TGN marker 58K
(localized in the perinuclear region) [18]) after 45 min and for
LAMP-1, a membrane protein primarily associated with lyso-
somal organelles [19], after 3 h, as described previously [20].
After treating with a blocking solution containing 10 %
normal goat serum (NGS) in PBS for 1 h, the cells were
incubated for 1 h at RT with the primary mouse monoclonal
anti-58K (Sigma) (for the samples incubated at 37 °C for
45 min) and mouse monoclonal anti-LAMP-1 (Abcam) (for
the samples incubated at 37 °C for 3 h) antibodies diluted
1:200 and 1:20, respectively, in PBS containing 1 % NGS.
Incubation was then carried out with goat anti-mouse Alexa
Fluor 488 secondary antibody (green fluorescent) (Invitrogen)
diluted 1:200 in PBS containing 1 % NGS for 1 h at RT. Cells
treated with non-specific mouse IgG were used as a control.
The TGN was visualized by perinuclear green fluorescent
staining after treatment with anti-58K and lysosomal vesicles
visualized by punctate green fluorescent staining after treat-
ment with LAMP-1. The cells were then further reacted with
Alexa Fluor-streptavidin 594 (red fluorescent) (Invitrogen,
Paisley, UK) for 30 min to visualize the biotin-labelled
EMD and the EMD Fractions; nuclei were stained blue using
Hoechst dye.
Phase-contrast and SEM analysis of EMD, Fraction C
and Fraction A interaction with PDL cells
EMD has previously been shown to precipitate and form
spheres and short rod-like structures on the PDL cell surface
in vitro and on PDL tissue section ex vivo [13], suggesting
that that the full-length proline-rich hydrophobic amelogenin
protein, a main component of EMD, might be involved in the
formation of such structures [13–15]. To examine whether the
TRAP-containing Fraction C and Fraction A also precipitate on
the PDL cell surface, 104 cells/well were seeded onto coverslips
in 24-well plates and cultured for 2–3 days in GM. EMD,
Fig. 1 Micrographs of biotinylated EMD, Fraction C and Fraction A
binding to PDL cells. Cells were cultured in the absence and presence
of EMD and the EMD fractions at 4 °C for 45 min, washed, fixed and
reacted with red fluorescent Alexa Fluor-streptavidin. A replicate control
culture of cells incubated in GM alone was washed, detached using
enzyme-free dissociation solution, fixed, centrifuged, reacted with red
fluorescent Alexa Flour-streptavidin and air-dried on glass slide. EMD
and the EMD Fractions are visualized by red fluorescent staining. The
nuclei are stained blue using Hoechst dye. White arrows show cell-
associated EMD, Fraction C and Fraction A. Note the absence of red
staining in the control GM alone culture
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Fraction C and Fraction A were then added (all at 30 μg/ml),
and the cells incubated for 24 h at 37 °C and examined by
phase-contrast microscopy for the possible formation of insolu-
ble particulate material. Replicate cultures were fixed in 1 %
glutaraldehyde at 4 °C for 30 min and prepared for SEM
analysis, using non-treated PDL cells as a control. To examine
whether precipitation is possible on tissue culture plastic in the
absence of any cells, 30 μg/ml EMD and the EMD Fractions in
GM were incubated on cover slips for 24 h at 37 °C, fixed in
1 % glutaraldehyde at 4 °C for 30 min and examined by SEM.
Results
Binding and uptake of EMD and EMD Fractions by PDL
cells
The results in Fig. 1 show that, under conditions suitable for
protein binding described in BMaterials and methods^, red
fluorescent staining corresponding to EMD, Fraction C and
Fraction A was observed to be localized primarily at the cell
membrane with little if any fluorescence present intracellular-
ly. Under control conditions where cells were treated with
dissociation solution post binding, there was no red fluores-
cent staining, indicating that EMD and the EMD Fractions
were digested/removed by the trypsin/EDTA treatment and
thus likely to have been mainly membrane-bound after incu-
bation at 4 °C.
When cells cultured with the biotinylated EMD and
EMD Fractions were then incubated for 3 h (protein in-
ternalization protocol as described in BMaterials and
methods^), the red fluorescence was localized intracellu-
larly, with a relatively diffuse cytosolic distribution
(Fig. 2). However, after 6 h, the red fluorescence was
localized mainly within a few (generally <10) large,
round intracellular vesicle-like structures. In control cul-
tures of cells treated with trypsin-EDTA (post-3 h inter-
nalizat ion protocol described in BMaterials and
methods^), the red fluorescent staining was still clearly
evident within large, round vesicle-like structures, indi-
cating that EMD and the EMD Fractions were internal-
ized after incubation at 37 °C for 3 and 6 h. Manual
counting of intracellular red fluorescent staining after
6 h showed that 8.5, 6.6 and 12.3 % to the total PDL
cells had internalized EMD, Fraction C and Fraction A,
respectively (Supplementary Figure 1).
Fig. 2 Micrographs of the internalization of biotinylated EMD, Fraction
C and Fraction A by PDL cells. Cells were incubated at 4 °C for 45min in
the absence and presence of EMD, Fraction C and Fraction A, then
washed and further incubated at 37 °C for 3 and 6 h, washed, fixed and
reacted with Alexa Fluor-streptavidin. Replicate cultures were trypsinized
to digest membrane-bound ligands and further cultured for 3 h to allow
the cells to re-attach and then reacted with red fluorescent Alexa Fluor-
streptavidin. EMD and the EMD Fractions are visualized by red fluores-
cent staining in the PDL cells. Note the white arrows showing the diffuse
distribution of the red fluorescent EMD and the EMD Fractions. Green
arrows show the localization of EMD and the EMD Fractions within
distinct intracellular vesicle-like structures. The nuclei are stained blue
using Hoechst dye
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Intracellular localization of EMD and the EMD Fractions
in PDL cells
Control cultures incubated in GM alone (with no EMD or
EMD Fractions) showed no red fluorescent staining, while
58K and LAMP-1 (markers of the TGN and lysosomes, re-
spectively) staining was observed (in replicate samples) by the
perinuclear green fluorescence of the 58K antigen and the
punctate green fluorescence of the LAMP-1 (lysosomal) anti-
gen, respectively, as shown previously (Tajika et al. 2004;
Bashour et al. 1998; Chen et al. 1985) (Fig. 3). The results
showed that there was a substantial number (generally >50) of
LAMP-1-positive diffuse structures, most probably lyso-
somes, as previously reported [7, 19] (Fig. 3).
When biotinylated EMD and EMD Fractions were incu-
bated with PDL cells at 4 °C for 45 min, washed, re-cultured
in GM at 37 °C for 45 min, stained for the TGN antigen 58K
(Alexa Fluor 488; green fluorescent) and then reacted with
streptavidin-Alexa Fluor 594, the red fluorescent staining
corresponding to EMD and the EMD Fractions was found
to co-localize mainly with the perinuclear green fluores-
cence of the TGN (Fig. 3). However, when the incubation
of the PDL cells was extended for 3 h at 37 °C, EMD,
Fraction C and Fraction A were found to be co-localized
primarily with LAMP-1-positive green fluorescent diffuse
structures, presumably lysosomes (Fig. 3). Notably, the
binding and intracellular localization of the biotinylated
chemically synthesized TRAP peptide were found to be
very similar to those of the EMD/EMD Fractions (Fig. 4),
indicating that the intracellular fate of this synthetic pep-
tide is likely to be similar to that of EMD, Fraction A and
Fraction C.
Fig. 3 Micrographs of co-labelled PDL cells, incubated with biotinylated
EMD, Fraction C and Fraction A (observed by red fluorescent staining)
and immunostained for either a TGN marker 58K or b lysosome marker
LAMP-1 (both observed by green fluorescent staining). PDL cells were
cultured in the absence and presence of EMD and the EMD Fractions at
4 °C for 45min, washed and re-cultured at 37 °C for 45min (a) or 3 h (b).
White arrows show co-localization of EMD and the EMD Fractions with
58K-positive TGN (a) and LAMP-1-positive structures (b). Nuclei are
stained blue using Hoechst dye
Clin Oral Invest
Formation of EMD, Fraction C and Fraction A
precipitates
Although EMD, Fraction C and Fraction A appeared to be read-
ily soluble in 0.1 % acetic acid (pH 4.1), based on the clear
appearance of these solutions, both EMD and Fraction A formed
globular precipitates when incubated with GM alone (pH 7.4) in
tissue culture plastic at 37 °C for 24 h (in the absence of any
cells), as shown by phase-contrast microscopy and SEM
(Supplementary Figure 2). In contrast, the low-molecular weight
Fraction C did not appear to form any type of precipitate on the
plastic surface (Supplementary Figure 2). When added to cul-
tures of PDL cells for 24 h at 37 °C, both EMD and Fraction A
formed spherical, aggregate-like structures that appeared to be
closely associated with the cell surface and also on the tissue
culture plastic surface, whereas no particulate material was de-
tected following incubation with Fraction C (Fig. 5). Thus, while
EMD and Fraction A precipitated on both the PDL cell surface
as well the plastic surface after incubation in GM, for 24 h (but
not by 3 or 6 h; data not shown), Fraction C produced no visible
evidence of precipitation at any time examined.
Discussion
EMD has been reported to induce PDL cell attachment, pro-
liferation and multi-lineage differentiation in vitro and peri-
odontal tissue regeneration in vivo [14, 21–26], although it is
not yet clear whether and which components of commercially
prepared (heat-treated) porcine EMD bind to specific trans-
membrane receptor(s) and potentiate PDL cell proliferation
and differentiation. However, previous reports examining the
role of mouse amelogenins in tooth development demonstrat-
ed that the full-length murine recombinant amelogenin
(M180) and its isoforms (M50) and (M73) bind to the receptor
CD107a (also known as LAMP-1) and to the receptor CD63
(also known as LAMP-3) on mouse embryonic dental follicle
cell membranes and transduce signals for odontogenic differ-
entiation [7, 9, 11], indicating that certain component(s) with-
in EMD may have an important signalling role in the process
of cell differentiation. In addition, it was reported previously
that when human osteoblasts were incubated with a crude
preparation of EMP at 37 °C for 3 h, protein component(s)
were found to be internalized into cells via clathrin-coated
pits, identified by simultaneous immunolabelling using anti-
EMP and anti-AP-2, a clathrin adaptor protein which is re-
sponsible for linking the ligand-receptor complex (cargo) into
clathrin-coated pits intracellularly (Reseland et al. 2006).
However, in this study, the binding of EMP to the cell mem-
brane and intracellular transport and fate of EMP were not
examined [12]. Moreover, EMP is a complex mixture of var-
ious proteins including amelogenin, sheathlins and enamelin,
while growth factors have also been found to be present in
such non-heat-treated crude preparations [27]. There is there-
fore uncertainty about the specificity of the antibody raised
against crude EMP and thus the specific component(s) that
may have been internalized into the osteoblasts [12].
The results of the present study, in attempting to elucidate
the mechanism(s) of this process, have shown for the first time
that at least some component(s) of the commercial preparation
of EMD and the EMD components Fraction A and Fraction C
bind to the PDL cell membrane at 4 °C. At 37 °C, these
proteins were subsequently internalized and transported to
the perinuclear region of the cells, co-localizing with the
TGN marker 58K after 45 min. After 3 h, these components
were found to have a diffuse cytosolic distribution co-
localizing with LAMP-1-positive lysosome-like structures.
A previous study using a recombinant mouse amelogenin
Fig. 4 Micrographs of PDL cells incubated with biotinylated TRAP (red
fluorescent) and co-labelled for intracellular vesicles (TGN and lyso-
somes; green fluorescence). PDL cells were cultured in the absence and
presence of TRAP at 4 °C for 45 min, washed and further incubated in
GMat 37 °C for 45min and 3 h.White arrows show the co-localization of
TRAP with 58K-positive TGN and LAMP-1-positive lysosomes-like
structures. White boxed area shows magnified micrographs of co-
localized TRAP with 58K-positive and LAMP-1-positive structures.
The nuclei are stained blue using Hoechst dye
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isoform (M50) showed that M50 peptide binds to the murine
ameloblast (LS8) membrane after incubation at 4 °C for 1 h
and internalizes and co-localizes with LAMP-1-positive lyso-
somes after further incubation for 1 h at 37 °C [7]. Similarly, a
recombinant mouse amelogenin (M180) was reported to in-
ternalize into mouse osteoblasts (MC3T3) and ameloblasts
(LS8) when incubated at for 1 h at 37 °C, having a diffuse
cytosolic distribution and co-localizing with LAMP-1-
positive vesicle-like structures [28]. The above studies were
carried out using a murine tooth/enamel developmental pro-
cess, compared with the present study which demonstrates the
interactions between EMD (commercially used as Emdogain®
for periodontal regeneration) and EMD components with hu-
man PDL cells. It is also notable that, in the present study,
when the heterogeneous PDL cell population used here was
incubated with EMD, Fraction C and Fraction A, only a pro-
portion of the cells bound and internalized these proteins,
suggesting that there is an as yet uncharacterized subpopula-
tion of cells within the PDL that expresses receptor(s) that
mediates direct interaction with EMD and the EMD
components.
During porcine development, EMP has been shown to be
secreted by ameloblasts, specialized epithelial cells having
unique extracellular projections mediating EMP secretion
(Tome’s processes), and to precipitate on the surface of these
same cells, promoting development of tooth-associated tissues
[14]. The present study observed that both EMD and the
higher molecular weight Fraction of EMD (Fraction A) pre-
cipitated and formed globular aggregate-like structures on the
PDL cell surface as well as on tissue culture plastic. Similarly,
recombinant mouse amelogenin (M180) has been reported to
also form insoluble supramolecular aggregates [27], suggest-
ing that this main components of EMD and Fraction A might
be responsible for the structures observed here. However, fur-
ther studies are required to determine which peptide(s) in the
heterogeneous preparation of Fraction A (peptides ranging
from 6 to 20 kDa) might be involved in forming aggregate-
like structures and also whether the macromolecules present
on the PDL surface are receptor-specific.
In contrast, although the present study found that the low-
molecular weight component(s) of EMD (e.g. of Fraction C)
did not precipitate and form such aggregate-like structures,
this Fraction, containing mainly the 5 kDa peptide (TRAP)
derived from full-length amelogenin, nevertheless has the po-
tential to stimulate vasculogenic and angiogenic differentia-
tion of PDL cells in vitro [1]. It is thus likely that at least
Fig. 5 Phase-contrast and SEM micrographs of PDL cells cultured in
GM in the absence and presence of EMD, fraction C and fraction A
(30 μg/ml) at 37 °C. Black arrows indicate globular-like structures on
the PDL cell surface after 24 h. White arrows indicate globular-like
structures of EMD and fraction A directly on the tissue culture plastic
after 24 h. Note the absence of globular-like structures in cultures treated
with fraction C
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Fraction C acts by a receptor-mediated endocytosis mecha-
nism rather than by a precipitation-related process, although
the role of phagocytosis cannot be entirely excluded since
fibroblastic cells, which have been reported to be present in
the PDL population [29], have also been shown to be capable
of internalizing insoluble macromolecules via phagocytosis
[30]. For example, collagen (300 kDa) is internalized by hu-
man gingival and PDL fibroblasts via ‘phagosomes’, a spe-
cialized intracellular phagocytic vesicle for intracellular
breakdown [30]. Thus, while the present study did not inves-
tigate phagocytosis of EMD and Fraction A, it is nevertheless
possible that insoluble aggregates of these components could
be subjected to phagocytic uptake and thereby contribute to
the functional activity of EMD.
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